Logiscreen

Recursion Pharmaceuticals Inc - Class A

$3.20
Market Cap 1.70B
ROE -50.4%
Gross Margin -49.8%
Debt/Equity 0.1
Current Ratio 5.0
Revenue QoQ -60.1%
EPS QoQ -0.4%
F-Score 3

About

Recursion Pharmaceuticals Inc - Class A

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-3.35
vs median 36.93
P/B
1.83
vs median 2.32
ROE
-0.54
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

URGNPGENATAIBCAXSTOKANAB
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics